1. Academic Validation
  2. NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma

NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma

  • Cancer Immunol Immunother. 2024 Nov 11;74(1):16. doi: 10.1007/s00262-024-03880-6.
Jiaxin Yin 1 Yuxiao Song 1 Yang Fu 2 Jun Wang 3 Zhimin Zhang 1 Shasha Ruan 1 Gaoli Liu 4 Bicheng Zhang 5
Affiliations

Affiliations

  • 1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
  • 2 Department of Oncology, Xiangyang Hospital, Hubei University of Chinese Medicine, Xiangyang, China.
  • 3 Department of Oncology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
  • 4 Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
  • 5 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China. bichengzhang@hotmail.com.
Abstract

The anti-tumor immune response is greatly hindered by the protumor polarization of tumor-associated macrophages (TAMs). Cancer-related inflammation plays a central role in TAMs protumor polarization. Our study explored the unique positive feedback loop between inflammasome and complement in TAMs. The present study identified NOD-like receptors family pyrin domain containing 12 (NLRP12) formed positive feedback with C1qA and drove TAMs protumor polarization via the LILRB4/NF-κB pathway. In addition, NLRP12 was predominantly expressed in TAMs and was associated with poorer prognosis in lung adenocarcinoma (LUAD) patients. Knocking down LILRB4 inhibited TAMs protumor polarization. NLRP12-overexpressing TAMs promoted tumor cells' malignant progression and inhibited T cells' proliferation and cytotoxic function. Lastly, NLRP12 knockout (NLRP12-/-) reversed macrophage polarization, enhanced T-cell anti-tumor immunity, and suppressed tumor growth. Our findings highlighted the essential role of NLRP12/C1qA positive feedback loop and the LILRB4/NF-κB pathway in promoting TAMs protumor polarization. Inhibition of NLRP12 suppressed tumor development and promoted immune response. NLRP12 may be a promising target for LUAD immunotherapy.

Keywords

C1qA; LILRB4; Lung adenocarcinoma; NF-κB; NLRP12; Tumor-associated macrophages.

Figures
Products
Inhibitors & Agonists
Other Products